Cargando…
In‐hospital therapy for worsening heart failure: black box or sweet spot?
Autores principales: | Tanaka, Atsushi, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120405/ https://www.ncbi.nlm.nih.gov/pubmed/33738973 http://dx.doi.org/10.1002/ehf2.13307 |
Ejemplares similares
-
Crosstalk between the liver and heart: revisited for prevention and treatment
por: Tanaka, Atsushi, et al.
Publicado: (2020) -
So‐far overlooked HFpEF patients with normal natriuretic peptide level need more evidence
por: Tanaka, Atsushi, et al.
Publicado: (2022) -
Association Between Periprocedural Heart Rate Trend and Postprocedural Worsening Heart Failure in Patients Receiving Catheter Ablation for Atrial Fibrillation
por: Kataoka, Naoya, et al.
Publicado: (2022) -
Exploration of the clinical benefits of sodium glucose co-transporter 2 inhibitors in diabetic patients with concomitant heart failure
por: Tanaka, Atsushi, et al.
Publicado: (2018) -
Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
por: Tanaka, Atsushi, et al.
Publicado: (2020)